<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-04T03:20:52Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/35302" metadataPrefix="marc">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/35302</identifier><datestamp>2026-03-11T07:21:47Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37953</setSpec></header><metadata><record xmlns="http://www.loc.gov/MARC21/slim" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
   <leader>00925njm 22002777a 4500</leader>
   <datafield ind2=" " ind1=" " tag="042">
      <subfield code="a">dc</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Aliaga-Gaspar, Pablo</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Brichette Mieg, Isabel</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Fernández-Arjona, María del Mar</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Rodríguez-Bada, José Luis</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Lopez-Moreno, Yolanda</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Serrano-Castro, Pedro Jesús</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Fernández Fernández, Oscar</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Ciano-Petersen, Nicolas Lundahl</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Oliver-Martos, Begoña</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="260">
      <subfield code="c">2024</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="520">
      <subfield code="a">The soluble type I IFN receptor (sIFNAR2) is produced by alternative splicing and is present in body fluids. &#xd;
Although it can modulate IFN-ß activity, its biological role remains unknown.&#xd;
Methods: An in-silico study was conducted to compare the structure of recombinant human soluble IFNAR2 (r sIFNAR2) with its native form. The antiviral activity of r-sIFNAR2, produced in BL21-bacteria and CHO cells, was &#xd;
tested using a cytopathic effect assay including appropriate controls. Viability and toxicity were assessed by MTT &#xd;
assays. Proteomic analysis using mass spectrometry was conducted in the A549/EMCV bioassay to elucidate the &#xd;
mechanism of action, and then it was validated by Western blot.&#xd;
Results: The BL21-sIFNAR2 had a sequence identity of 83.6 % with the native form, showing variations only in &#xd;
terminal regions. BL21-sIFNAR2 and CHO-sIFNAR2 showed significantly higher percentage of cell viability &#xd;
compared to the viral control, similar to IFN-ß. Cell viability with BL21-sIFNAR2 was comparable to the cell &#xd;
control across all tested concentrations.&#xd;
Proteomic analysis revealed an up regulation of pathways related with autophagy (macroautophagy, autophagy, &#xd;
pexophagy, and mitophagy) with an SQSTM1 overexpression that was then confirmed by Western Blot, espe&#xd;
cially after virus infection. However, pathways related to interferon signaling, and antiviral mechanisms &#xd;
mediated by IFN-stimulated genes were down-regulated.&#xd;
Conclusion: r-sIFNAR2 exhibits significant antiviral activity regardless of the expression system used for its &#xd;
production and good safety profile, suggesting its use as a potential antiviral drug. Proteins related to autophagy &#xd;
are involved in the protection from the virus. This study highlights the biological relevance of soluble cytokine &#xd;
receptors as effectors so far overlooked</subfield>
   </datafield>
   <datafield ind1="8" ind2=" " tag="024">
      <subfield code="a">Pablo Aliaga-Gaspar, Isabel Brichette-Mieg, MdM Fernández-Arjona, José Luis Rodríguez-Bada, Yolanda López-Moreno, Pedro Serrano-Castro, Oscar Fernández-Fernández, Nicolás Lundahl Ciano-Petersen, Begoña Oliver-Martos, Recombinant soluble type I interferon receptor exerts antiviral activity by inducing proteins related to autophagy, Biomedicine &amp; Pharmacotherapy, Volume 181, 2024, 117678, ISSN 0753-3322, https://doi.org/10.1016/j.biopha.2024.117678.</subfield>
   </datafield>
   <datafield ind1="8" ind2=" " tag="024">
      <subfield code="a">https://hdl.handle.net/10630/35302</subfield>
   </datafield>
   <datafield ind1="8" ind2=" " tag="024">
      <subfield code="a">https://doi.org/10.1016/j.biopha.2024.117678</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Farmacología</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Medicina</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Interferón</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Receptores celulares</subfield>
   </datafield>
   <datafield ind2="0" ind1="0" tag="245">
      <subfield code="a">Recombinant soluble type I interferon receptor exerts antiviral activity by  inducing proteins related to autophagy</subfield>
   </datafield>
</record>
</metadata></record></GetRecord></OAI-PMH>